{"id":"https://openalex.org/W2099535490","doi":"https://doi.org/10.1124/dmd.114.057224","title":"4\u03b2-Hydroxycholesterol as an Endogenous Biomarker of CYP3A Activity in Cynomolgus Monkeys","display_name":"4\u03b2-Hydroxycholesterol as an Endogenous Biomarker of CYP3A Activity in Cynomolgus Monkeys","publication_year":2014,"publication_date":"2014-03-05","ids":{"openalex":"https://openalex.org/W2099535490","doi":"https://doi.org/10.1124/dmd.114.057224","mag":"2099535490","pmid":"https://pubmed.ncbi.nlm.nih.gov/24595680"},"language":"en","primary_location":{"id":"doi:10.1124/dmd.114.057224","doi":"https://doi.org/10.1124/dmd.114.057224","is_oa":false,"landing_page_url":"https://doi.org/10.1124/dmd.114.057224","pdf_url":null,"source":{"id":"https://openalex.org/S145039780","display_name":"Drug Metabolism and Disposition","issn_l":"0090-9556","issn":["0090-9556","1521-009X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Disposition","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100343532","display_name":"Ke Li","orcid":"https://orcid.org/0000-0003-0296-7189","observed_orcids":["https://orcid.org/0000-0003-0296-7189"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ke Li","raw_affiliation_strings":["Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108718326","display_name":"Sylvia Zhao","orcid":"https://orcid.org/0009-0005-8963-0870","observed_orcids":["https://orcid.org/0009-0005-8963-0870"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylvia Zhao","raw_affiliation_strings":["Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100384142","display_name":"Lingling Zhang","orcid":"https://orcid.org/0000-0001-7555-8138","observed_orcids":["https://orcid.org/0000-0001-7555-8138","https://orcid.org/0009-0006-8330-9784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lingling Zhang","raw_affiliation_strings":["Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101649577","display_name":"Xiaoyun Wu","orcid":"https://orcid.org/0000-0001-5160-2763","observed_orcids":["https://orcid.org/0000-0001-5160-2763"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoyun Wu","raw_affiliation_strings":["Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037866135","display_name":"Shu Pan","orcid":"https://orcid.org/0000-0002-9118-3281","observed_orcids":["https://orcid.org/0000-0002-9118-3281"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pan Shu","raw_affiliation_strings":["Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100322879","display_name":"Yang Wang","orcid":"https://orcid.org/0000-0003-0842-2446","observed_orcids":["https://orcid.org/0000-0003-0842-2446","https://orcid.org/0009-0003-0019-8264"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yang Wang","raw_affiliation_strings":["Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016556832","display_name":"Hao Feng","orcid":"https://orcid.org/0000-0001-5420-1690","observed_orcids":["https://orcid.org/0000-0001-5420-1690"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hao Feng","raw_affiliation_strings":["Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111532339","display_name":"Zhe-ming Gu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zheming Gu","raw_affiliation_strings":["Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111890462","display_name":"Helen Han Hsu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Han Hsu","raw_affiliation_strings":["Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Sciences Asia Pacific, Janssen Research & Development, Shanghai, China (K.L., S.Z., X.W., Y.W., H.H.H.) and XBL-China, Nanjing, China (L.Z., P.S., H.F., Z.G.)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":0.9,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.6758291,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"42","issue":"5","first_page":"839","last_page":"843"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/4beta-hydroxycholesterol","display_name":"4\u03b2-hydroxycholesterol","score":1.0},{"id":"https://openalex.org/keywords/cyp3a-activity","display_name":"CYP3A activity","score":0.8669999837875366},{"id":"https://openalex.org/keywords/endogenous-biomarkers","display_name":"endogenous biomarkers","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.9169999957084656},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cyp3a-induction","display_name":"CYP3A induction","score":0.8949999809265137},{"id":"https://openalex.org/keywords/cyp3a5","display_name":"CYP3A5","score":1.0},{"id":"https://openalex.org/keywords/cholesterol-metabolism","display_name":"cholesterol metabolism","score":0.9330000281333923},{"id":"https://openalex.org/keywords/midazolam","display_name":"midazolam","score":0.8500000238418579},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8209999799728394},{"id":"https://openalex.org/keywords/preclinical-safety-evaluation","display_name":"preclinical safety","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C11824378","wikidata":"https://www.wikidata.org/wiki/Q5014970","display_name":"CYP3A","level":4,"score":0.9000930786132812},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.6988555192947388},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.636917233467102},{"id":"https://openalex.org/C2778000748","wikidata":"https://www.wikidata.org/wiki/Q423071","display_name":"Midazolam","level":3,"score":0.6264879703521729},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5277717113494873},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5008583068847656},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.49915599822998047},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4797183871269226},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.47728195786476135},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.47118356823921204},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.43340715765953064},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37422841787338257},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3286094069480896},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.29744404554367065},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20432841777801514},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004790","descriptor_name":"Enzyme Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006888","descriptor_name":"Hydroxycholesterols","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008874","descriptor_name":"Midazolam","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008874","descriptor_name":"Midazolam","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1124/dmd.114.057224","doi":"https://doi.org/10.1124/dmd.114.057224","is_oa":false,"landing_page_url":"https://doi.org/10.1124/dmd.114.057224","pdf_url":null,"source":{"id":"https://openalex.org/S145039780","display_name":"Drug Metabolism and Disposition","issn_l":"0090-9556","issn":["0090-9556","1521-009X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Disposition","raw_type":"journal-article"},{"id":"pmid:24595680","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24595680","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism and disposition: the biological fate of chemicals","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.903.2376","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.903.2376","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://dmd.aspetjournals.org/content/42/5/839.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1593954768","https://openalex.org/W1967574902","https://openalex.org/W1977210074","https://openalex.org/W1998736820","https://openalex.org/W2015329733","https://openalex.org/W2022524111","https://openalex.org/W2040073279","https://openalex.org/W2061150976","https://openalex.org/W2080787906","https://openalex.org/W2092656325","https://openalex.org/W2110739749","https://openalex.org/W2139521634","https://openalex.org/W2165863524"],"related_works":["https://openalex.org/W7099733913","https://openalex.org/W2161883000","https://openalex.org/W2911336266","https://openalex.org/W7096220076","https://openalex.org/W2913866147","https://openalex.org/W2797994387","https://openalex.org/W1593954768","https://openalex.org/W7215024188","https://openalex.org/W2531142929","https://openalex.org/W2346110522"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}